Trial intelligence / Profile preview

Fosmidomycin and Clindamycin with Artesunate in Malaria

NCT01002183Phase 2Withdrawn

Sponsor
DMG Deutsche Malaria
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fosmidomycin in Plasmodium falciparum malaria, sponsored by DMG Deutsche Malaria. Status: withdrawn.

02

Drugs

fosmidomycin
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT01002183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01002183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call